Details for Patent: 12,539,314
✉ Email this page to a colleague
Which drugs does patent 12,539,314 protect, and when does it expire?
Patent 12,539,314 protects POTASSIUM CHLORIDE and is included in one NDA.
Summary for Patent: 12,539,314
| Title: | Aqueous oral compositions including potassium chloride |
| Abstract: | The present disclosure provides an oral liquid composition comprising potassium chloride, free of alcohol, free of parabens, and with enhanced stability. The present disclosure further provides methods of using the oral liquid compositions comprising potassium chloride, and which are free of alcohol and parabens, for the treatment of hypokalemia in patients with or without metabolic alkalosis. |
| Inventor(s): | Shivaji Phadke, Vaishnavi Parikh |
| Assignee: | Genus Lifesciences Inc |
| Application Number: | US18/504,280 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 12,539,314
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 206814-001 | Dec 22, 2014 | AA | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Genus Lifesciences | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 206814-002 | Dec 22, 2014 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
